New drug KIVU-107 targets Hard-to-Treat cancers in early trial
NCT ID NCT07229313
First seen Nov 16, 2025 · Last updated May 12, 2026 · Updated 20 times
Summary
This study tests a new drug called KIVU-107 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to target and kill cancer cells while limiting harm to healthy cells. The main goals are to find the safest dose and check for side effects. About 76 adults will take part in this early-stage trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kivu Trial Site
RECRUITINGSanta Monica, California, 90403, United States
-
Kivu Trial Site
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Kivu Trial Site
RECRUITINGSydney, New South Wales, Australia
-
Kivu Trial Site
RECRUITINGBrisbane, Queensland, Australia
-
Kivu Trial Site
RECRUITINGAdelaide, South Australia, Australia
-
Kivu Trial Site
RECRUITINGGeelong, Victoria, Australia
Conditions
Explore the condition pages connected to this study.